· Periodic ReportMajor
Q3 operating profit KRW 11.9 billion, up 46.6% from a year earlier
PharmiCell sold KRW 37.0 billion in Q3 and earned KRW 11.9 billion from its main business, up 46.6% from a year earlier and down 9.8% from the prior quarter.
Pharmicell Co.,Ltd. Disclosures
005690 · KOSPI · Based on DART filings
Disclosures
3 total · 20 per page
· Single Sales/Supply Contract
Signs KRW 7.4 billion electronic materials supply contract with Doosan
Pharmicell Co.,Ltd. signed a KRW 7.4 billion electronic materials supply contract with DOOSAN CO.,LTD (6.49% of recent revenue).
· Report on Large Shareholdings
CEO Kim Hyun Soo group keeps 11.72% stake, extends share-backed loan
Kim Hyun Soo and related parties kept their 11.72% stake in Pharmicell Co.,Ltd. and extended a share-backed loan covering 399,003 shares, due 2027.01.04.
Catch the next disclosure fast
Get app alerts for new disclosures from Pharmicell Co.,Ltd..